Literature DB >> 8009866

Induction of developmentally programmed cell death and activation of HIV by sodium butyrate.

M R Sadaie1, G L Hager.   

Abstract

Apoptosis is an important regulatory process during normal development and maturation. We find that the proliferation-arresting and differentiation-inducing compound sodium n-butyrate (NaB) triggers a marked host chromatin degradation. This apoptotic process is independent of, but commensurate with, a rapid increase in viral mRNA synthesis and subsequent release of HIV-1 virus in transformed human cell lines harboring tat- (HLM1) or tat+ (U1, ACH-2) dormant HIV-1 proviruses. This compound stimulates a reversible accumulation of the characteristic viral mRNAs at a much faster rate than two other DNA degradation inducers such as tumor necrosis factor-alpha and phorbol 12-myristate 13-acetate. The transcriptional activator butyrate analogue, alpha-amino-n-butyrate, failed to cause similar phenotypic changes. These results suggest that common regulatory signals may be involved in activation of apoptosis genes and latent provirus by NaB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8009866     DOI: 10.1006/viro.1994.1372

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

Authors:  C Van Lint; S Emiliani; E Verdin
Journal:  Gene Expr       Date:  1996

2.  n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes.

Authors:  F Turin; C Borel; M Benchaib; A Kay; C Jamard; C Guguen-Guillouzo; C Trépo; O Hantz
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis.

Authors:  V Kolesnitchenko; L King; A Riva; Y Tani; S J Korsmeyer; D I Cohen
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.

Authors:  Meisheng Zhou; Longwen Deng; Vincent Lacoste; Hyeon Ung Park; Anne Pumfery; Fatah Kashanchi; John N Brady; Ajit Kumar
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis.

Authors:  Diane L Bolton; Beom-Ik Hahn; Eugenia A Park; Laura L Lehnhoff; Felicita Hornung; Michael J Lenardo
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation.

Authors:  Vladimir Klichko; Nancy Archin; Rupinderjeet Kaur; Ginger Lehrman; David Margolis
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection.

Authors:  Boris Kantor; Hong Ma; Jennifer Webster-Cyriaque; Paul E Monahan; Tal Kafri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

8.  Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.

Authors:  Lakshmi Ramakrishna; Krishnamurthy Kumar Anand; Kumarasamypet M Mohankumar; Udaykumar Ranga
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

Authors:  C Van Lint; S Emiliani; M Ott; E Verdin
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

10.  Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection.

Authors:  B A Antoni; P Sabbatini; A B Rabson; E White
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.